SCHEMBL7847367

SCHEMBL7847367

CC(C)(C)OC(=O)NCC12CN(c3cc4c(cc3F)c(=O)c(C(=O)O)cn4C3CC3F)CC1CCO2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.44
KDM4E B2RXH2 7/20 0.44
HPGD P15428 5/20 0.43
LMNA P02545 4/20 0.43
HSD17B10 Q99714 4/20 0.43
MAPT P10636 1/20 0.43
CYP1A2 P05177 1/20 0.42
TOP2A P11388 1/20 0.42
CYP2C9 P11712 1/20 0.42
TOP2B Q02880 1/20 0.42
PIK3CG P48736 2/20 0.38
HTT P42858 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PIK3CD O00329 1/20 0.38
PIK3R1 P27986 1/20 0.38
PIK3CA P42336 1/20 0.38
DRD3 P35462 1/20 0.37
CYP3A4 P08684 1/20 0.37
BRD4 O60885 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7847371 1.00 ALDH1A1 (0.44) ALDH1A1KDM4EHPGDLMNAHSD17B10
SCHEMBL8923588 0.92 KDM4E (0.53) ALDH1A1KDM4EHPGDLMNAHSD17B10
SCHEMBL7498548 0.92 ALDH1A1 (0.35) ALDH1A1KDM4EHPGDLMNAHSD17B10
SCHEMBL7847782 0.89 ALDH1A1 (0.41) ALDH1A1KDM4EHPGDLMNAHSD17B10
SCHEMBL7843329 0.88 ALDH1A1 (0.41) ALDH1A1KDM4EHPGDLMNAHSD17B10
SCHEMBL8925166 0.88 CYP3A4 (0.39) ALDH1A1KDM4EHPGDLMNAHSD17B10
SCHEMBL8925167 0.88 CYP3A4 (0.39) ALDH1A1KDM4EHPGDLMNAHSD17B10
SCHEMBL7844361 0.87 ALDH1A1 (0.40) ALDH1A1KDM4EHPGDLMNAHSD17B10
SCHEMBL7834705 0.87 ALDH1A1 (0.40) ALDH1A1KDM4EHPGDLMNAHSD17B10
SCHEMBL8922944 0.86 ALDH1A1 (0.44) ALDH1A1KDM4EHPGDLMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010036941-A1 Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolonecarboxylic acid and -naphthyridonecarboxylic acid derivatives for the therapy of Helicobacter pylori infections and associated gastroduodenal disorders PETERSEN UWE (DE) 2001-11-01 US disclosed
US-6288081-B1 Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for treating Helicobacter pylori infections and the gastroduodenal diseases associated therewith BAYER AKTIENGESELLSCHAFT (DE) 2001-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010036941-A1 Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolonecarboxylic acid and -naphthyridonecarboxylic acid derivatives for the therapy of Helicobacter pylori infections and associated gastroduodenal disorders OXER1, AOC3, PAM ALDH1A1 670/4885KDM4E 1947/4885HPGD 26/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.